Mandate

Vinge advises Concordia Bus in connection with new share issue and refinancing

September 08, 2009

Vinge has advised Concordia Bus in connection with the implementation of a rights issue subject to pre-emption rights for the existing shareholders and the exchange of the company’s existing senior notes in the amount of EUR 130 million for new senior notes. In connection with the rights issue, all of the company’s outstanding preference shares were redeemed. The new issue will generate just over SEK 800 million for the company.

Concordia Bus is one of Europe’s ten largest public transportation groups and the Nordic region’s leading bus transportation group. The group has approximately 7,000 employees and a turnover of approximately SEK 5.5 billion.

The Vinge team consisted of Ola Sandersson, Maria-Pia Midenbäck Hope, Bo Adrianzon, Mattias Schömer, Maria Doeser, Dain Nevonen, Nils-Taro Lock, Elin Hjort and Christian Granqvist.

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026